ABOUT PEDIATRIC MIGRAINE STUDY
About This Migraine Study
This is a research study, or clinical trial, to test a medication approved by the FDA for the treatment of acute migraine in adults. The purpose of this study is to learn how well the study drug works and how safe the study drug is to treat migraine in children and teens compared to placebo. There will be 1,440 study participants (approximately 1,200 will be adolescents and 240 will be children under the age of 12).
Pediatric Migraine Study Details
This study will test the safety of rimegepant for use in the acute treatment of migraine in the pediatric population. If you qualify, your participation in this study will last approximately 19 weeks and will include up to 4 study visits to the study center. Eligible participants will be randomly assigned to receive a dose of study drug or placebo.
For more detailed information visit clinicaltrials.gov.
What is a Migraine?
Migraine is a chronic and debilitating disorder that affects approximately 15% of the adult population. In young children, usually those below the age of 15 years, migraine headaches may be bi-lateral or unilateral, and may be non-throbbing. The patient may look ill and pale, may feel dizzy, have blurred vision, and fever. Nausea and vomiting are frequent, particularly in young children (defined as 7 years of age). Patients tend to avoid light (photophobia), noise (phonophobia), strong odors, and movement.